International audienceThis work demonstrates how the rapid steady state T1 MRI technique for cerebral blood volume fraction (BVf) quantification can be used with intraperitoneal Gd-DOTA injections in mice at 4.7 T. The peak signal amplitude after intravenous administration (0.7 mmol/kg) and the steady state signal amplitude reached 15 min after intraperitoneal administration (6 mmol/kg) in the same mice lead to equivalent BVf measures in the order of 0.02 in the brain. The resulting time window for BVf quantification is ≈30 min and allows for cerebral BVf mapping with increased spatial resolution or signal-to-noise ratio, or for monitoring functional BVf changes. A cerebral BVf increase of up to 25% induced by the vasodilator acetazolamide ...
PURPOSE: Quantitative dynamic contrast-enhanced MRI requires an accurate arterial input function (AI...
Magnetic resonance imaging (MRI) is a powerful method for in vivo quantification of tissue properfie...
The blood-brain barrier (BBB) prevents effective delivery of most therapeutic agents to the brain. I...
International audienceThis work demonstrates how the rapid steady state T1 MRI technique for cerebra...
International audienceThis paper describes a new rapid steady-state T(1) (RSST(1)) method for mappin...
NMR microimaging has the potential to elucidate cerebrovascular abnormalities in mouse models. In th...
Recent advance in nuclear magnetic resonance (NMR) microimaging has enabled in vivo cerebral blood v...
<p>Mice have become the preferred model system for studying brain function and disease. With the pow...
CEREBRAL BLOOD VOLUME FRACTION (CBVF) MAPPING BY MAGNETIC RESONANCE IMAGING (MRI) CAN PROVIDE INFORM...
Recent advance in NMR microimaging has enabled in vivo CBV mapping with high spatial resolution[1]. ...
This work demonstrates technical approaches to high-quality magnetic resonance imaging (MRI) of smal...
Serial imaging studies can be useful in characterizing the pathologic and physiologic remodeling of ...
The cerebral blood flow (CBF) is a potential biomarker for neurological disease. However, the arteri...
Blood flow imaging is an important tool in cerebrovascular research. Mice are of special interest be...
Intraperitoneal (IP) injection represents an attractive alternative route of radiotracer administrat...
PURPOSE: Quantitative dynamic contrast-enhanced MRI requires an accurate arterial input function (AI...
Magnetic resonance imaging (MRI) is a powerful method for in vivo quantification of tissue properfie...
The blood-brain barrier (BBB) prevents effective delivery of most therapeutic agents to the brain. I...
International audienceThis work demonstrates how the rapid steady state T1 MRI technique for cerebra...
International audienceThis paper describes a new rapid steady-state T(1) (RSST(1)) method for mappin...
NMR microimaging has the potential to elucidate cerebrovascular abnormalities in mouse models. In th...
Recent advance in nuclear magnetic resonance (NMR) microimaging has enabled in vivo cerebral blood v...
<p>Mice have become the preferred model system for studying brain function and disease. With the pow...
CEREBRAL BLOOD VOLUME FRACTION (CBVF) MAPPING BY MAGNETIC RESONANCE IMAGING (MRI) CAN PROVIDE INFORM...
Recent advance in NMR microimaging has enabled in vivo CBV mapping with high spatial resolution[1]. ...
This work demonstrates technical approaches to high-quality magnetic resonance imaging (MRI) of smal...
Serial imaging studies can be useful in characterizing the pathologic and physiologic remodeling of ...
The cerebral blood flow (CBF) is a potential biomarker for neurological disease. However, the arteri...
Blood flow imaging is an important tool in cerebrovascular research. Mice are of special interest be...
Intraperitoneal (IP) injection represents an attractive alternative route of radiotracer administrat...
PURPOSE: Quantitative dynamic contrast-enhanced MRI requires an accurate arterial input function (AI...
Magnetic resonance imaging (MRI) is a powerful method for in vivo quantification of tissue properfie...
The blood-brain barrier (BBB) prevents effective delivery of most therapeutic agents to the brain. I...